Trial shows antihypertension drug may improve pancreatic cancer outcomes

Adding the blood-pressure drug losartan to the intensive chemo and radiation protocol for treating locally advanced pancreatic cancer allowed complete removal of the tumor in 61 percent of trial participants and significantly improved survival rates.

Sue McGreevey
May 30, 2019 | harvard

~5 mins

Tags: health-medicine blood-pressure carlos-fernandez-del-castillo janet-murphy jennifer-wo losartan massachusetts-general-hospital mgh pancreatic-cancer rakesh-k-jain theodore-hang

Page 1 of 1